Literature DB >> 30563939

Treatment resistant depression: what are the options?

Greta McLachlan1.   

Abstract

Entities:  

Year:  2018        PMID： 30563939     DOI： 10.1136/bmj.k5354

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Dietary Long-Chain n-3 Polyunsaturated Fatty Acid Supplementation Alters Electrophysiological Properties in the Nucleus Accumbens and Emotional Behavior in Naïve and Chronically Stressed Mice.

Authors:  Mathieu Di Miceli; Maud Martinat; Moïra Rossitto; Agnès Aubert; Shoug Alashmali; Clémentine Bosch-Bouju; Xavier Fioramonti; Corinne Joffre; Richard P Bazinet; Sophie Layé
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

Review 2.  Management of Treatment-Resistant Depression: Challenges and Strategies.

Authors:  Daphne Voineskos; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

3.  Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts.

Authors:  João M Bessa; Serafim Carvalho; Inês B Cunha; Milene Fernandes; Ana Matos-Pires; Rui Neves; Albino J Oliveira-Maia; Susana Santos; Vítor Santos
Journal:  Front Psychiatry       Date:  2022-03-30       Impact factor: 4.157

4.  The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders.

Authors:  Marta Jóźwiak-Bębenista; Paulina Sokołowska; Małgorzata Siatkowska; Cecilia Analia Panek; Piotr Komorowski; Edward Kowalczyk; Anna Wiktorowska-Owczarek
Journal:  Pharmaceutics       Date:  2022-04-12       Impact factor: 6.525

5.  Experiences of treatment-resistant mental health conditions in primary care: a systematic review and thematic synthesis.

Authors:  Amelia Talbot; Charlotte Lee; Sara Ryan; Nia Roberts; Kamal R Mahtani; Charlotte Albury
Journal:  BMC Prim Care       Date:  2022-08-16

6.  Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report.

Authors:  Laurent Elkrief; Olivier Payette; Jean-Nicolas Foucault; Christophe Longpré-Poirier; Maxime Richard; Véronique Desbeaumes Jodoin; Paul Lespérance; Jean-Philippe Miron
Journal:  Front Psychiatry       Date:  2022-09-21       Impact factor: 5.435

7.  Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.

Authors:  Aaron J Courtenay; Emma McAlister; Maelíosa T C McCrudden; Lalit Vora; Lilach Steiner; Galit Levin; Etgar Levy-Nissenbaum; Nava Shterman; Mary-Carmel Kearney; Helen O McCarthy; Ryan F Donnelly
Journal:  J Control Release       Date:  2020-03-19       Impact factor: 9.776

Review 8.  Cellular Response to Unfolded Proteins in Depression.

Authors:  Mateusz Kowalczyk; Edward Kowalczyk; Paweł Kwiatkowski; Łukasz Łopusiewicz; Monika Talarowska; Monika Sienkiewicz
Journal:  Life (Basel)       Date:  2021-12-10

9.  Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression.

Authors:  Kinza Degerlund Maldi; Peter Asellus; Anna Myléus; Fredrik Norström
Journal:  BMC Psychiatry       Date:  2021-12-07       Impact factor: 3.630
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.